Federal contract award
75N95024F00001
CLINICAL EVALUATION OF PHENSERINE TARTRATE EXTENDED CONTROLLED RELEASE TABLET (ECRT) FORMULATION IN EARLY MILD ALZHEIMER'S DISEASE AND MILD TO MODERATE TRAUMATIC BRAIN INJURY.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541990 — All Other Professional, Scientific, and Technical Services |
| PSC | B504 — Chemical/Biological Studies and Analysis |
| Parent award / vehicle | 75N95024D00002 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $962.5K |
| Current contract value | $962.5K |
| Potential contract value / ceiling | $962.5K |
| Start date | Feb 1, 2024 |
| Current end date | Jan 31, 2026 |
| Potential end date | Jan 31, 2026 |
| Latest award activity | Jan 21, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 21, 2025 | P00001 | $0 | CLINICAL EVALUATION OF PHENSERINE TARTRATE EXTENDED CONTROLLED RELEASE TABLET (ECRT) FORMULATION IN EARLY MILD ALZHEIMER'S DISEASE AND MILD TO MODERATE TRAUMATIC BRAIN INJURY. |
| Jan 31, 2024 | 0 | $962.5K | CLINICAL EVALUATION OF PHENSERINE TARTRATE EXTENDED CONTROLLED RELEASE TABLET (ECRT) FORMULATION IN EARLY MILD ALZHEIMER'S DISEASE AND MILD TO MODERATE TRAUMATIC BRAIN INJURY. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.